Benzinga | Apr 15, 2021 07:08AM EDT

Atlantic Equities Initiates Coverage On Edwards Lifesciences with Neutral Rating, Announces Price Target of $85

Atlantic Equities analyst James Mainwaring initiates coverage on Edwards Lifesciences (NYSE:EW) with a Neutral rating and announces Price Target of $85.